![The Lancet Oncology in conversation with artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/4e/3e/ef/4e3eefcf-c4c6-a704-062b-d40be7b03ea7/mza_5325872108990078460.jpg/100x100bb.jpg)
Neerja Bhatla on a new quadrivalent HPV vaccine
The Lancet Oncology in conversation with
English - November 29, 2023 14:00 - 12 minutes - 8.54 MB - ★★★★★ - 1 ratingMedicine Health & Fitness Education cancer radiotherapy chemotherapy mrna Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00480-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv